Anguilla vs Montenegro: Tuberculosis patients living with HIV receiving antiretroviral therapy
Anguilla
0 patients
in 2016
Montenegro
0 patients
in 2021
Anguilla rank
141st
Montenegro rank
141st
Tuberculosis patients living with HIV receiving antiretroviral therapy over time
- Anguilla
- Montenegro
How they compare
Anguilla currently reports 0 patients against 0 patients in Montenegro, a difference of 0 patients.
The two have swapped places 2 times across 9 shared years of data; in 2006 it was Montenegro ahead.
Anguilla ranks 141st and Montenegro ranks 141st of 183 countries.
Montenegro has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Anguilla | Montenegro | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0 patients | 0.6667 patients | 0.6667 patients | Montenegro |
| 2010s | 0.1667 patients | 0.5 patients | 0.3333 patients | Montenegro |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis patients living with hiv receiving antiretroviral therapy, Anguilla or Montenegro?
- Anguilla, at 0 patients against 0 patients in Montenegro as of 2016.
- What is the difference in tuberculosis patients living with hiv receiving antiretroviral therapy between Anguilla and Montenegro?
- 0 patients, with Anguilla ahead.
- How many years of comparable data are there for Anguilla and Montenegro?
- 9 years are reported by both, from 2006 to 2016.
- How do Anguilla and Montenegro rank globally for tuberculosis patients living with hiv receiving antiretroviral therapy?
- Anguilla ranks 141st and Montenegro ranks 141st of 183 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data, published as Tuberculosis patients living with HIV receiving antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of tuberculosis patients who are living with HIV and receiving antiretroviral therapy.